Published in Am J Obstet Gynecol on March 01, 2005
Prevalence of symptomatic pelvic floor disorders in US women. JAMA (2008) 7.81
Defining success after surgery for pelvic organ prolapse. Obstet Gynecol (2009) 3.46
Traditional native tissue versus mesh-augmented pelvic organ prolapse repairs: providing an accurate interpretation of current literature. Int Urogynecol J (2011) 2.27
Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J (2011) 2.18
Incidence and lifetime risk of pelvic organ prolapse surgery in Denmark from 1977 to 2009. Int Urogynecol J (2014) 2.16
Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J (2015) 2.12
Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.96
Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J (2013) 1.76
Treatment patterns and survival outcomes in patients with cervical cancer complicated by complete uterine prolapse: a systematic review of literature. Int Urogynecol J (2015) 1.72
The age distribution, rates, and types of surgery for pelvic organ prolapse in the USA. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.70
Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol (2014) 1.70
What is clinically relevant prolapse? An attempt at defining cutoffs for the clinical assessment of pelvic organ descent. Int Urogynecol J (2014) 1.66
Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol (2008) 1.61
Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J (2009) 1.60
Body image and sexuality in women with pelvic organ prolapse. Urol Nurs (2009) 1.54
Surgical management of mesh-related complications after prior pelvic floor reconstructive surgery with mesh. Int Urogynecol J (2011) 1.52
Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int Urogynecol J (2010) 1.50
Anterior vaginal wall prolapse and voiding dysfunction in urogynecology patients. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.45
Validation of a simplified technique for using the POPQ pelvic organ prolapse classification system. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.41
Changes in connective tissue in patients with pelvic organ prolapse--a review of the current literature. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.41
Sequence variant in the laminin gamma1 (LAMC1) gene associated with familial pelvic organ prolapse. Hum Genet (2006) 1.23
Distribution of pelvic organ support measures in a population-based sample of middle-aged, community-dwelling African American and white women in southeastern Michigan. Am J Obstet Gynecol (2008) 1.18
Familial transmission of genitovaginal prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.12
Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter cross-sectional study. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.11
Risk factors for the recurrence of pelvic organ prolapse after vaginal surgery: a review at 5 years after surgery. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.11
The aetiology of prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.09
Patterns of pessary care and outcomes for medicare beneficiaries with pelvic organ prolapse. Female Pelvic Med Reconstr Surg (2013) 1.09
Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.08
Magnetic resonance imaging-based three-dimensional model of anterior vaginal wall position at rest and maximal strain in women with and without prolapse. Int Urogynecol J (2010) 1.08
Randomized trial of fascia lata and polypropylene mesh for abdominal sacrocolpopexy: 5-year follow-up. Int Urogynecol J (2010) 1.03
Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery. Int Urogynecol J (2012) 1.03
Measuring outcomes in urogynecological surgery: "perspective is everything". Int Urogynecol J (2012) 1.03
Comparison between trans-obturator trans-vaginal mesh and traditional anterior colporrhaphy in the treatment of anterior vaginal wall prolapse: results of a French RCT. Int Urogynecol J (2013) 1.01
Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial. J Clin Endocrinol Metab (2014) 1.01
Why do stress and urge incontinence co-occur much more often than expected? Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.01
Anterior vaginal wall prolapse: a randomized controlled trial of SIS graft versus traditional colporrhaphy. Int Urogynecol J (2010) 1.00
Family history as a risk factor for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.99
Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. Obstet Gynecol (2011) 0.98
Emerging concepts for pelvic organ prolapse surgery: What is cure? Curr Urol Rep (2011) 0.98
Do racial differences in knowledge about urogynecologic issues exist? Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.97
Does vaginal size impact sexual activity and function? Int Urogynecol J (2009) 0.95
Pelvic organ prolapse symptoms in relation to POPQ, ordinal stages and ultrasound prolapse assessment. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.95
Risk factors for pelvic floor repair after hysterectomy. Obstet Gynecol (2009) 0.95
Uterine prolapse. BMJ (2007) 0.94
Clinical challenges in the management of vaginal prolapse. Int J Womens Health (2014) 0.94
Pelvic organ prolapse and collagen-associated disorders. Int Urogynecol J (2011) 0.93
Spanish language translation of pelvic floor disorders instruments. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.92
POP-Q stage I prolapse: is it time to alter our terminology? Int Urogynecol J (2014) 0.92
Cardinal and deep uterosacral ligament lines of action: MRI based 3D technique development and preliminary findings in normal women. Int Urogynecol J (2012) 0.92
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J (2016) 0.91
POP-Q 2.0: its time has come! Int Urogynecol J (2014) 0.90
Rectal prolapse. Clin Colon Rectal Surg (2011) 0.89
An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J (2016) 0.89
Quantification of pelvic organ prolapse in mice: vaginal protease activity precedes increased MOPQ scores in fibulin 5 knockout mice. Biol Reprod (2008) 0.89
Urinary incontinence in community-dwelling older Mexican American and European American women. Arch Gerontol Geriatr (2008) 0.89
A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J (2012) 0.88
Risk factors for prolapse development in white, black, and Hispanic women. Female Pelvic Med Reconstr Surg (2011) 0.87
Validation of a German version of the P-QOL Questionnaire. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.87
Is laminin gamma-1 a candidate gene for advanced pelvic organ prolapse? Am J Obstet Gynecol (2010) 0.86
Functional significance of muscarinic receptor expression within the proximal and distal rat vagina. Am J Physiol Regul Integr Comp Physiol (2009) 0.86
Prolapse symptoms in overweight and obese women before and after weight loss. Female Pelvic Med Reconstr Surg (2012) 0.85
Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial. Int Urogynecol J (2012) 0.85
Two-year outcomes after vaginal prolapse reconstruction with mesh pelvic floor repair system. Female Pelvic Med Reconstr Surg (2013) 0.85
Prolapse and sexual function 8 years after neovagina according to Shears: a study of 43 cases with Mayer-von Rokitansky-Küster-Hauser syndrome. Int Urogynecol J (2012) 0.84
Does COLIA1 SP1-binding site polymorphism predispose women to pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.84
Pelvic organ prolapse and stress urinary incontinence: A review of etiological factors. Indian J Urol (2007) 0.84
Is there a difference in patient and physician quality of life evaluation in pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.84
Vaginal parity and pelvic organ prolapse. J Reprod Med (2010) 0.84
Reoperation for pelvic organ prolapse within 10 years of primary surgery for prolapse. Int Urogynecol J (2012) 0.84
Association between pelvic organ prolapse and stress urinary incontinence with collagen. Exp Ther Med (2014) 0.84
Multicenter inter-examiner agreement trial for the validation of simplified POPQ system. Int Urogynecol J (2011) 0.83
The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse. Int Urogynecol J (2012) 0.83
LOXL1 deficiency negatively impacts the biomechanical properties of the mouse vagina and supportive tissues. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.82
Prevalence of genital prolapse symptoms in primary care: a cross-sectional survey. Int Urogynecol J (2014) 0.82
Polymorphism of a COLIA1 gene Sp1 binding site in Korean women with pelvic organ prolapse. Yonsei Med J (2009) 0.81
To mesh or not to mesh: a review of pelvic organ reconstructive surgery. Int J Womens Health (2015) 0.80
The FIGO assessment scoring system (FASS): a new holistic classification tool to assess women with pelvic floor dysfunction: validity and reliability. Int Urogynecol J (2015) 0.80
Reproductive morbidity among Iranian women; issues often inappropriately addressed in health seeking behaviors. BMC Public Health (2011) 0.80
Uterine prolapse in a 19 year old pregnant woman: a case report. J Turk Ger Gynecol Assoc (2009) 0.80
Stapled transanal longitudinal posterior proctectomy (STALPP) in total rectal prolapse: a 7-year experience. Tech Coloproctol (2013) 0.80
Validation, reliability, and responsiveness of Prolapse Quality of Life Questionnaire (P-QOL) in a Brazilian population. Int Urogynecol J (2011) 0.80
Validation and cultural translation for Brazilian Portuguese version of the Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Floor Distress Inventory (PFDI-20). Int Urogynecol J (2016) 0.79
The role of smooth muscle in the pathogenesis of pelvic organ prolapse--an immunohistochemical and morphometric analysis of the cervical third of the uterosacral ligament. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.79
Correlation of pelvic organ prolapse staging with lower urinary tract symptoms, sexual dysfunction, and quality of life. Int Urogynecol J (2013) 0.79
The development of pelvic organ prolapse after colposuspension: a prospective, long-term follow-up study on the prevalence and predisposing factors. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.79
High uterosacral vault suspension vs Sacrocolpopexy for treating apical defects: a randomized controlled trial with twelve months follow-up. Int Urogynecol J (2015) 0.78
Can sex survive pelvic floor surgery? Int Urogynecol J (2010) 0.78
Incontinence: should mesh be used to correct anterior vaginal prolapse? Nat Rev Urol (2011) 0.78
Physical activity and the pelvic floor. Am J Obstet Gynecol (2015) 0.78
Patient goal attainment in vaginal prolapse repair with and without mesh. Int Urogynecol J (2012) 0.78
Vaginal noise: prevalence, bother and risk factors in a general female population aged 45-85 years. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.78
Fixation of Light Weight Polypropylene Mesh with n-Butyl-2-cyanocrylate in Pelvic Floor Surgery: Experimental Design Approach in Sheep for Effectiveness Evaluation. Biomed Res Int (2015) 0.78
Concomitant apical suspensory procedures in women with anterior vaginal wall prolapse in the United States in 2011. Int Urogynecol J (2015) 0.78
Potential relevance of pre-operative quality of life questionnaires to identify candidates for surgical treatment of genital prolapse: a pilot study. BMC Urol (2012) 0.77
Variability of current symptoms in women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.77
Characterizing the phenotype of advanced pelvic organ prolapse. Female Pelvic Med Reconstr Surg (2012) 0.76
Matrix Metalloproteinase-1 Expression in Women With and Without Pelvic Organ Prolapse: A Systematic Review and Meta-analysis. Clin Transl Sci (2016) 0.76
Management of recurrent vault prolapse. Int Urogynecol J (2011) 0.75
Correlation of POP-Q posterior compartment measures with defecatory dysfunction. Int Urogynecol J (2012) 0.75
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
The diploid genome sequence of an Asian individual. Nature (2008) 46.29
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet (2008) 12.51
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Sequencing of 50 human exomes reveals adaptation to high altitude. Science (2010) 11.27
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell (2010) 8.74
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell (2004) 8.06
Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model (2006) 7.93
Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol (2009) 7.59
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36
Acute renal failure and sepsis. N Engl J Med (2004) 7.18
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
High-performance neuroprosthetic control by an individual with tetraplegia. Lancet (2012) 6.66
The dog genome: survey sequencing and comparative analysis. Science (2003) 5.84
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med (2008) 5.54
The draft genome of the transgenic tropical fruit tree papaya (Carica papaya Linnaeus). Nature (2008) 5.54
Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA (2004) 5.34
The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med (2008) 5.14
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res (2007) 4.95
Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations. Cancer Res (2008) 4.30
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res (2008) 4.17
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83
Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell (2013) 3.81
Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke (2008) 3.81
Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A (2010) 3.78
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest (2004) 3.75
Discovery and annotation of functional chromatin signatures in the human genome. PLoS Comput Biol (2009) 3.61
Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med (2005) 3.55
Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn (2012) 3.54
Surgical treatment of giant coronary artery aneurysm. J Thorac Cardiovasc Surg (2005) 3.53
ChromaSig: a probabilistic approach to finding common chromatin signatures in the human genome. PLoS Comput Biol (2008) 3.46
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proc Natl Acad Sci U S A (2009) 3.39
Characteristics associated with differences in survival among black and white women with breast cancer. JAMA (2013) 3.35
Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril (2012) 3.33
Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Res (2011) 3.25
Effects of a universal classroom behavior management program in first and second grades on young adult behavioral, psychiatric, and social outcomes. Drug Alcohol Depend (2008) 3.22
Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res (2010) 3.17
Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells (2005) 3.16
A recalibrated molecular clock and independent origins for the cholera pandemic clones. PLoS One (2008) 3.16
Effectiveness of strengthened stimulation during acupuncture for the treatment of Bell palsy: a randomized controlled trial. CMAJ (2013) 3.15
Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time. Drug Alcohol Depend (2008) 3.09
Quantum-sized carbon dots for bright and colorful photoluminescence. J Am Chem Soc (2006) 3.08
Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med (2012) 3.08
Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell (2011) 3.07
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model (2010) 3.04
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet (2013) 3.02
Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett (2013) 2.99
The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome (2007) 2.82
Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes (2010) 2.81
NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants. Nature (2012) 2.76
Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol Cell Biol (2003) 2.74
U-Pb ages from the neoproterozoic Doushantuo Formation, China. Science (2005) 2.71
Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol (2008) 2.68
Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2004) 2.65
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation (2012) 2.58
1-(2-Benzoyl-1-phenyl-eth-yl)-4-[(2-hy-droxy-1-naphth-yl)methyl-idene-amino]-3-methyl-1H-1,2,4-triazole-5(4H)-thione. Acta Crystallogr Sect E Struct Rep Online (2011) 2.58
Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A (2006) 2.54
Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med (2006) 2.53
Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet (2012) 2.51
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell (2013) 2.50
Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J Infect Dis (2009) 2.49
Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell (2008) 2.46
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest (2012) 2.41
Calibrating the end-Permian mass extinction. Science (2011) 2.41
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res (2009) 2.40
Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol (2007) 2.38
Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol (2003) 2.38
Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2012) 2.34
PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science (2010) 2.31
Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea (2007) 2.30
Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells. Nature (2004) 2.29
SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data. Nucleic Acids Res (2011) 2.27
Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog (2006) 2.26
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med (2010) 2.26
Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol (2005) 2.24
Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat Protoc (2010) 2.24
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest (2003) 2.23
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res (2006) 2.23
Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice. Circulation (2011) 2.21
Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med (2009) 2.19
RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis. Cell Cycle (2011) 2.18
4,5-Diamino-benzene-1,2-dicarbonitrile. Acta Crystallogr Sect E Struct Rep Online (2009) 2.17
Inferring missing genotypes in large SNP panels using fast nearest-neighbor searches over sliding windows. Bioinformatics (2007) 2.17
Sleep disorders, health, and safety in police officers. JAMA (2011) 2.16
Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction. Circ Res (2012) 2.16
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med (2007) 2.16
DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis (2012) 2.16
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. Cancer Discov (2011) 2.14
Glomerular filtration rate can be accurately predicted using lean mass measured by dual-energy X-ray absorptiometry. Nephrol Dial Transplant (2005) 2.13
Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol (2006) 2.12
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors. Cancer (2014) 2.12
Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases. Kidney Int (2010) 2.11